Predisposing factors of blood brain barrier penetration from docetaxel during lung cancer treatment: Preliminary study

MLA

Theodore Kontakiotis, et al. “Predisposing Factors of Blood Brain Barrier Penetration from Docetaxel during Lung Cancer Treatment: Preliminary Study.” Journal of Clinical Oncology, vol. 24, June 2006, p. 17102. EBSCOhost, https://doi.org/10.1200/jco.2006.24.18_suppl.17102.

APA

Theodore Kontakiotis, A. Chatzopoulou, P. Pousinis, G. Theodoridis, K. Zarogoulidis, & D. Patakas. (2006). Predisposing factors of blood brain barrier penetration from docetaxel during lung cancer treatment: Preliminary study. Journal of Clinical Oncology, 24, 17102. https://doi.org/10.1200/jco.2006.24.18_suppl.17102

Chicago

Theodore Kontakiotis, A. Chatzopoulou, P. Pousinis, G. Theodoridis, K. Zarogoulidis, and D. Patakas. 2006. “Predisposing Factors of Blood Brain Barrier Penetration from Docetaxel during Lung Cancer Treatment: Preliminary Study.” Journal of Clinical Oncology 24 (June): 17102. doi:10.1200/jco.2006.24.18_suppl.17102.